Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol Drug Seen Helping Body Attack Lung Cancer: Health
Bloomberg
Wednesday, May 30, 2012 - 10:21am
tags:
Bristol-Myers Squibb, BMS-936558, lung cancer
Is Dendreon's Downgrade Deserved?
Motley Fool
Wednesday, May 30, 2012 - 10:20am
tags:
Dendreon, downgrades, Provenge, prostate cancer, JNJ, Zytiga
Bulls Buy Zalicus As Novartis Collaboration Gains Traction
Seeking Alpha
Wednesday, May 30, 2012 - 10:19am
tags:
Zalicus, Novartis, Sanofi
The House PDUFA Bill Would Do What?
Pharmalot
Tuesday, May 29, 2012 - 5:10pm
tags:
congress, FDA, PDUFA
Cell Therapeutics' JAK2 Inhibitor Acquisition Is A Smart Pick-Up
Seeking Alpha
Tuesday, May 29, 2012 - 5:09pm
tags:
Cell Therapeutics, JAK inhibitors, Novartis, Pfizer, Onyx, Incyte, pacritinib
A New Look At Galena's NeuVax While Lowering Analyst's Raised Red Flags
Seeking Alpha
Tuesday, May 29, 2012 - 5:08pm
tags:
Galena Biopharma, NeuVax
Merck Suffers Same Flaw As Facebook
Seeking Alpha
Tuesday, May 29, 2012 - 4:48pm
tags:
Merck, Facebook, Ampio Pharmaceuticals, Catalyst Pharmaceutical Partners
Johnson & Johnson says FDA did not approve once-per-day version of HIV pill Prezista
Yahoo/AP
Tuesday, May 29, 2012 - 4:48pm
tags:
FDA, HIV, JNJ, Prezista
Teva won't launch generic Lipitor, Economic Times says
Yahoo/Fly on the Wall
Tuesday, May 29, 2012 - 4:47pm
tags:
generics, Lipitor, Teva Pharmaceuticals, Pfizer
Does Pfizer Have Institutional Stock Support for its Future Product Pipeline?
Wall St. Cheat Sheet
Tuesday, May 29, 2012 - 4:45pm
tags:
Pfizer
Who Should Buy Amylin?
Motley Fool
Tuesday, May 29, 2012 - 4:44pm
tags:
M&A, Amylin, Sanofi, Merck, Bristol-Myers Squibb, Takeda, AstraZeneca
GlaxoSmithKline and AstraZeneca Invest in Antibiotic Research
PharmaLive
Tuesday, May 29, 2012 - 4:43pm
tags:
antibiotic resistance, antibiotics, GSK, AstraZeneca
[video] NPS Pharma CEO: Market Recognizing Pipeline Potential
TheStreet.com
Tuesday, May 29, 2012 - 11:33am
tags:
Pharma CEOs, NPS Pharmaceuticals, Natpara, Gattex
These Biotechs May Break Out While Vivus And Arena Battle It Out
Seeking Alpha
Tuesday, May 29, 2012 - 11:25am
tags:
Arena Pharmaceuticals, Vivus, YM BioSciences, Astex
ASCO Stocks To Consider This Week
Seeking Alpha
Tuesday, May 29, 2012 - 11:15am
tags:
ASCO, Arena Pharmaceuticals, Vivus, JNJ, Bayer, Onyx, Pharmacyclics
Keryx and Peers are Strong Buys
Motley Fool
Tuesday, May 29, 2012 - 11:14am
tags:
Keryx, Arena Pharmaceuticals, Dendreon, Novartis, Indenix, Spectrum Pharmaceuticals
Teva Issues 2012 Outlook
Yahoo/Zacks
Tuesday, May 29, 2012 - 11:12am
tags:
Teva Pharmaceuticals, guidance
Human Genome shareholder sues board over GSK "poison pill," Reuters reports
Yahoo/Fly on the Wall
Tuesday, May 29, 2012 - 11:11am
tags:
Human Genome Sciences, GSK, poison pill, M&A
Abbott Labs: Learn From Grace Groner
Seeking Alpha
Tuesday, May 29, 2012 - 11:10am
tags:
Abbott Laboratories, GSK, Merck, Pfizer, Novartis, Sanofi
Arena is Hands Down a Better Investment than Vivus
Motley Fool
Monday, May 28, 2012 - 11:25am
tags:
Arena Pharmaceuticals, Vivus, obesity, Qnexa, lorcaserin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.